<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><id>3268</id>
	<dc:title xml:lang="en-US">Neurodevelopmental disorders: 2021 update</dc:title>
	<dc:creator>Zamora-Moratalla, Alfonsa</dc:creator>
	<dc:creator>Martínez de Lagrán, María</dc:creator>
	<dc:creator>Dierssen, Mara</dc:creator>
	<dc:subject xml:lang="en-US">Autism spectrum disorder</dc:subject>
	<dc:subject xml:lang="en-US">ADS</dc:subject>
	<dc:subject xml:lang="en-US">Neurodegenerative disorders</dc:subject>
	<dc:subject xml:lang="en-US">Next generation sequencing</dc:subject>
	<dc:subject xml:lang="en-US">Microbiome</dc:subject>
	<dc:subject xml:lang="en-US">Preterm birth</dc:subject>
	<dc:description xml:lang="en-US">One of the current challenges in the field of neurodevelopmental disorders (NDDs) is still to determine their underlying aetiology and risk factors. NDDs comprise a diverse group of disorders primarily related to neuro-developmental dysfunction including autism spectrum disorder (ASD), developmental delay, intellectual dis-ability (ID), and attention-deficit/hyperactivity disorder (ADHD) that may present with a certain degree of cognitive dysfunction and high prevalence of neuropsychiatric outcomes. Last year, advances in human ge-nomics have begun to shed light on the genetic architecture of these disorders and large-scale sequencing studies are starting to reveal mechanisms that range from unique genomic DNA methylation patterns (i.e. “episignatures”) to highly polygenic conditions. In addition, the contribution of de novo somatic mutations to neurodevelopmental diseases is being recognized. However, progressing from genetic findings to underlying neuropathological mechanisms has proved challenging, due to the increased resolution of the molecular and genetic assays. Advancement in modelling tools is likely to improve our understanding of the origin of neuro-developmental disorders and provide insight into their developmental mechanisms. Also, combined in vivo editing of multiple genes and single-cell RNA-sequencing (scRNA-seq) are bringing us into a new era of un-derstanding the molecular neuropathology of NDDs.</dc:description>
	<dc:publisher xml:lang="de-DE">Free Neuropathology</dc:publisher>
	<dc:publisher xml:lang="en-US">Free Neuropathology</dc:publisher>
	<dc:date>2021-03-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Review</dc:type>
	<dc:format>text/html</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.uni-muenster.de/Ejournals/index.php/fnp/article/view/3268</dc:identifier>
	<dc:identifier>10.17879/freeneuropathology-2021-3268</dc:identifier>
	<dc:source xml:lang="de-DE">Free Neuropathology; Bd. 2 (2021); 6</dc:source>
	<dc:source xml:lang="en-US">Free Neuropathology; Vol. 2 (2021); 6</dc:source>
	<dc:source>2699-4445</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.uni-muenster.de/Ejournals/index.php/fnp/article/view/3268/3289</dc:relation>
	<dc:relation>https://www.uni-muenster.de/Ejournals/index.php/fnp/article/view/3268/3284</dc:relation>
	<dc:relation>urn:nbn:de:hbz:6:3-freeneuropathology-2021-32846</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Alfonsa Zamora-Moratalla, María Martínez de Lagrán, Mara Dierssen</dc:rights>
</oai_dc:dc>